Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY24.70 CNY
Change Today -0.07 / -0.28%
Volume 15.7M
002653 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

xizang haisco pharmaceutic-a (002653) Snapshot

Open
CNY25.30
Previous Close
CNY24.77
Day High
CNY25.30
Day Low
CNY22.29
52 Week High
06/3/15 - CNY39.50
52 Week Low
12/23/14 - CNY16.88
Market Cap
26.7B
Average Volume 10 Days
10.2M
EPS TTM
CNY0.42
Shares Outstanding
1.1B
EX-Date
05/27/15
P/E TM
58.8x
Dividend
CNY0.20
Dividend Yield
0.81%
Current Stock Chart for XIZANG HAISCO PHARMACEUTIC-A (002653)

Related News

No related news articles were found.

xizang haisco pharmaceutic-a (002653) Related Businessweek News

No Related Businessweek News Found

xizang haisco pharmaceutic-a (002653) Details

Xizang Haisco Pharmaceutical Group Co., Ltd., together with its subsidiaries, develops, produces, and sells drugs in China. The company offers capsules, tablets, granules, and bulk drugs in the fields of cardiovascular, anti-infection, digestive system, nervous and mental system, hepatopathy, diabetes mellitus, etc., as well as liver disease, parenteral nutrition, first-aid, antibiotics, anesthesia, and tumor adjuvant. It is also developing nalmefene hydrochloride injection, dolasetron mesylate injection, cefodizime sodium for injection, hydroxyethyl starch and sodium chloride injection, medium and long chain fat emulsion injection, and compound amino acids injection. The company was founded in 2000 and is based in Chengdu, China.

Founded in 2000

xizang haisco pharmaceutic-a (002653) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

xizang haisco pharmaceutic-a (002653) Key Developments

Xizang Haisco Pharmaceutical Group Co., Ltd., Special/Extraordinary Shareholders Meeting, Jul 31, 2015

Xizang Haisco Pharmaceutical Group Co., Ltd., Special/Extraordinary Shareholders Meeting, Jul 31, 2015., at 14:00 China Standard Time. Agenda: To consider repurchase of partial shares of the company to implement the employee stock ownership plan.

Xizang Haisco Pharmaceutical Group Co., Ltd. Declares to Set Up Haisco Holdings Limited in Seychelles

Xizang Haisco Pharmaceutical Group Co., Ltd. declared to set up Haisco Holdings Limited in Seychelles through wholly owned Hong Kong subsidiary and other related parties with USD 17 million, taking a further step in M&A through cooperation by controlling shareholder and other investors.

Xizang Haisco Pharmaceutical Group Co., Ltd., Special/Extraordinary Shareholders Meeting, Jul 16, 2015

Xizang Haisco Pharmaceutical Group Co., Ltd., Special/Extraordinary Shareholders Meeting, Jul 16, 2015., at 14:00 China Standard Time. Agenda: To consider connected transaction regarding setup of an overseas subsidiary and joint investment in setup of a company with related parties; to consider capital increase in a Hongkong-based subsidiary; and to change of the Company's name and the business scope.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002653:CH CNY24.70 CNY -0.07

002653 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002653.
View Industry Companies
 

Industry Analysis

002653

Industry Average

Valuation 002653 Industry Range
Price/Earnings 57.6x
Price/Sales 22.2x
Price/Book 12.4x
Price/Cash Flow 56.8x
TEV/Sales 20.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XIZANG HAISCO PHARMACEUTIC-A, please visit www.haisco.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.